“That’s the hope,” said Robert W. Finberg, MD, chairman of UMass Memorial’s Department of Medicine. “If we can eliminate the virus, we’d be living in a much healthier place.”
In October, Dr. Finberg and his team were given a $10 million contract from the U.S. Department of Defense to research better ways to predict the flu virus and its consistent transformation. “The difference with the flu is that it evolves very rapidly — it changes itself,” Dr. Finberg added.
The researchers are primarily focusing on genetic sequencing. The influenza virus is able to infect more people through its consistent sequence changes. The UMass team hopes to produce a counter vaccine by predicting the virus’ potential sequence changes.
More articles on integration and physician issues:
Integris joins Mayo Clinic Care Network
Idaho governor supports multi-state medical school program
CVS affiliates with 4 health providers: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
